drugset / Trial / NCT02235844
Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)
Phase 1
Completed
1 enrolled
Allergy and Asthma Consultants, Wichita, Kansas
Aidan Foundation · collabNeil H. Riordan PhD · collab
NaSingle-groupOpen-labelTreatment
Summary
This research study is designed to evaluate the effects of human umbilical cord mesenchymal stem cells (UC-MSCs), on Duchenne's muscular dystrophy (DMD). The potential muscle regenerative and anti-inflammatory properties of UC MSCs position them as a possible treatment option for DMD. Both of these properties could lead to potential benefits for a DMD patient.
Timeline
- Start
- 2014-09
- Primary completion
- 2017-09-30
- Completion
- 2017-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mesenchymal stem cells | Cell therapy | — | — |